187 related articles for article (PubMed ID: 20553141)
21. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
22. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
[TBL] [Abstract][Full Text] [Related]
23. St. John's Wort enhances the synaptic activity of the nucleus of the solitary tract.
Vance KM; Ribnicky DM; Hermann GE; Rogers RC
Nutrition; 2014; 30(7-8 Suppl):S37-42. PubMed ID: 24985104
[TBL] [Abstract][Full Text] [Related]
24. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
25. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
26. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
Güzelcan Y; Scholte WF; Assies J; Becker HE
Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
[TBL] [Abstract][Full Text] [Related]
27. Effect of St. John's wort on free radical production.
Hunt EJ; Lester CE; Lester EA; Tackett RL
Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
[TBL] [Abstract][Full Text] [Related]
28. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
29. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy.
Traynor NJ; Beattie PE; Ibbotson SH; Moseley H; Ferguson J; Woods JA
Toxicol Lett; 2005 Sep; 158(3):220-4. PubMed ID: 15890476
[TBL] [Abstract][Full Text] [Related]
30. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation.
Schempp CM; Lüdtke R; Winghofer B; Simon JC
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):125-8. PubMed ID: 10885442
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
32. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
Simbrey K; Winterhoff H; Butterweck V
Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
[TBL] [Abstract][Full Text] [Related]
33. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P
Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473
[TBL] [Abstract][Full Text] [Related]
34. Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L.
Conforti F; Statti GA; Tundis R; Bianchi A; Agrimonti C; Sacchetti G; Andreotti E; Menichini F; Poli F
Nat Prod Res; 2005 Apr; 19(3):295-303. PubMed ID: 15702645
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect.
Hatanaka J; Shinme Y; Kuriyama K; Uchida A; Kou K; Uchida S; Yamada S; Onoue S
Drug Metab Pharmacokinet; 2011; 26(6):551-8. PubMed ID: 21914965
[TBL] [Abstract][Full Text] [Related]
36. Effects of St John's wort and its active constituents, hypericin and hyperforin, on isolated rat urinary bladder.
Valeri A; Capasso R; Valoti M; Pessina F
J Pharm Pharmacol; 2012 Dec; 64(12):1770-6. PubMed ID: 23146040
[TBL] [Abstract][Full Text] [Related]
37. PKC-mediated potentiation of morphine analgesia by St. John's Wort in rodents and humans.
Galeotti N; Farzad M; Bianchi E; Ghelardini C
J Pharmacol Sci; 2014; 124(4):409-17. PubMed ID: 24739262
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus.
Butterweck V; Böckers T; Korte B; Wittkowski W; Winterhoff H
Brain Res; 2002 Mar; 930(1-2):21-9. PubMed ID: 11879791
[TBL] [Abstract][Full Text] [Related]
39. St. John's wort reversal of meningeal nociception: a natural therapeutic perspective for migraine pain.
Galeotti N; Ghelardini C
Phytomedicine; 2013 Jul; 20(10):930-8. PubMed ID: 23578992
[TBL] [Abstract][Full Text] [Related]
40. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
